Amevive Wisdom Acquired Through Real-World Evidence - 2 (A.W.A.R.E.-2) Program: Long-Term Study.
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2013
At a glance
- Drugs Alefacept (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions; Biomarker; Therapeutic Use
- Acronyms AWARE-2
- Sponsors Astellas Pharma
- 09 Mar 2011 Planned end date changed from 1 Mar 2011 to 1 Jan 2011 as reported by ClinicalTrials.gov.
- 09 Mar 2011 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 29 Oct 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.